All Stories

  1. Identification of high-risk age groups for cisplatin-induced nausea and vomiting in young patients with sarcoma

    Article • Journal of Pharmaceutical Health Care and Sciences, September 2025, Springer Science + Business Media

    Takeshi Aoyama

  2. Age-Stratified Risk of Carboplatin-Induced Nausea and Vomiting in Lung Cancer Patients

    Article • Oncology, March 2025, Karger Publishers

    Takeshi Aoyama

  3. Extravasation associated with cancer drug therapy: multidisciplinary guideline of the Japanese Society of Cancer Nursing, Japanese Society of Medical Oncology, and Japanese Society of Pharmaceutical Oncology

    Article • ESMO Open, October 2024, Elsevier

    Takeshi Aoyama

  4. Safety evaluation of fixed‐dose nivolumab in patients with gastric cancer

    Article • Health Science Reports, June 2022, Wiley

    Takeshi Aoyama

  5. Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers

    Article • Cancer Chemotherapy and Pharmacology, February 2021, Springer Science + Business Media

    Takeshi Aoyama

  6. Impact of Primary Pegfilgrastim Prophylaxis on Relative Dose Intensity in Neoadjuvant/Adjuvant FEC-100 Chemotherapy

    Article • Anticancer Research, February 2020, International Institute of Anticancer Research

    Takeshi Aoyama

  7. Comparison of cisplatin-induced nephrotoxicity

    Article • Journal of Chemotherapy, January 2020, Taylor & Francis

    Takeshi Aoyama

  8. Association of Immune-Related Adverse Events with Pembrolizumab Efficacy in the Treatment of Advanced Urothelial Carcinoma

    Article • Oncology, January 2020, Karger Publishers

    Takeshi Aoyama

  9. Factors Associated With Regorafenib Adherence With Metastatic Colorectal Cancer

    Article • Patient Preference and Adherence, October 2019, Taylor & Francis

    Dr MITSUKUNI SUENGA, Takeshi Aoyama

  10. Regorafenib-Induced Hand‐Foot Skin Reaction Is More Severe on the Feet Than on the Hands

    Article • Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, May 2019, Cognizant Communication Corporation

    Takeshi Aoyama

  11. Association of Hand-Foot Skin Reaction with Regorafenib Efficacy in the Treatment of Metastatic Colorectal Cancer

    Article • Oncology, January 2019, Karger Publishers

    Takeshi Aoyama

  12. Antiemetic Effects of Granisetron or Metoclopramide Administered Prior to Amrubicin Monotherapy

    Article • Oncomedicine, January 2017, Ivyspring International Publisher

    Takeshi Aoyama

  13. Self-Reported Adherence to Trifluridine and Tipiracil Hydrochloride for Metastatic Colorectal Cancer: A Retrospective Cohort Study

    Article • Oncology, January 2016, Karger Publishers

    Takeshi Aoyama